Navigation Links
Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia
Date:5/21/2008

Active cellular immunotherapy holds promise because it may provide patients with a meaningful clinical benefit, such as survival, combined with low toxicity. The Company has its headquarters in Seattle, Washington and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit http://www.dendreon.com.

Except for historical information contained herein, this news release contains forward-looking statements that are subject to, risks and uncertainties surrounding the presentation of data to the FDA and approval of product applications by the FDA and risks and uncertainties inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics. Factors that may cause such differences include risks related to our limited operating history, risks associated with completing our clinical trials, the risk that the safety and/or efficacy results of existing clinical trials or from additional clinical trials will not support approval, the risk that the FDA may interpret data differently than we do or require more data or a more rigorous analysis of data than expected, the risk that the FDA will not approve a product for which a biologics license has been applied, the risk that the results of a clinical trial may not be indicative of results obtained in a later clinical trial, risks that we may lack the financial resources and access to capital to fund required clinical trials or commercialization of products, our dependence on the efforts of third parties, and our dependence on intellectual property. Further information on the factors and risks that could affect Dendreon's business, financial condition and results of operations are contained in Dendreon's public disclosure filings with the U.S. Securities and Exchange Commission, which are available at

SOURCE Dendreon Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival
2. Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis
5. Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association
6. Neurobiological Technologies, Inc. Presents Dosing Rationale for Viprinex(TM) (ancrod) at the European Stroke Conference
7. Napo Presents at ISPOR Meeting in Toronto
8. Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session
9. Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)
10. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
11. Idenix Pharmaceuticals Presents Positive Preclinical Data on HCV Programs at The Annual Meeting of The European Association for the Study of the Liver (EASL)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... May 24, 2013  Regulatory and marketplace changes ... many organizations, priority list. Forward-thinking ... understand a strong Medical Affairs function ... development, market education , and regulatory compliance. ... vital bridge between an organization and one of ...
(Date:5/24/2013)... LAKES, N.J. , May 24, 2013  BD (Becton, ... global medical technology company, announced today that it will present ... Conference on Thursday, May 30, 2013, at 10:40 a.m. (ET). ... be accessed from the BD corporate website at www.bd.com/investors ... 6, 2013.    About BD BD ...
(Date:5/24/2013)... BEVERLY HILLS, Calif. , May 24, 2013 /PRNewswire-iReach/ ... the state,s leading non-profit substance abuse services organization, is ... at the Beverly Hills Hotel on June 6, 2013.  ... event to raise funds for the adolescent residential treatment ... as well as honor individuals whose accomplishments have positive ...
Breaking Medicine Technology:Building Medical Affairs Capabilities to Ensure Organizational Success across Key Operational Areas 2Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg 2Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg 3
... 19 Encorium Group, Inc. (Nasdaq: ENCO ), (the ... in over 30 countries for many of the world,s leading pharmaceutical ... AG, a corporation organized in Switzerland and its wholly-owned ... , Chile , Switzerland , India and ...
... Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer ... Paris, France -based, privately held group of companies and worldwide manufacturer and ... alliance. Terms of the agreement include: , ... Strategic Investment – ELITech will ...
Cached Medicine Technology:Encorium Group, Inc. Acquires Progenitor International Research, a Vaccine Focused Emerging Market CRO 2Encorium Group, Inc. Acquires Progenitor International Research, a Vaccine Focused Emerging Market CRO 3Encorium Group, Inc. Acquires Progenitor International Research, a Vaccine Focused Emerging Market CRO 4Corgenix Medical Corp. and the ELITech Group Establish Strategic Alliance 2Corgenix Medical Corp. and the ELITech Group Establish Strategic Alliance 3Corgenix Medical Corp. and the ELITech Group Establish Strategic Alliance 4
(Date:5/25/2013)... Springs, FL (PRWEB) May 25, 2013 ... Dallas-Ft. Worth, Texas. It is the fifth largest media market ... Dallas is the number one visitor destination in Texas and ... cultural gateway to the American West as it is home ... activities everyone will enjoy from sports to the arts. Residents ...
(Date:5/25/2013)... May 25 (HealthDay News) -- Many viruses and parasites ... and leptospirosis -- a bacteria-borne illness than can result ... at dog parks, according to a veterinarian. ... and even the air, said Dr. Susan Nelson, a ... Center. "Many of these serious diseases can be fatal, ...
(Date:5/25/2013)... 25, 2013 Radius Engineering International ... company in the US and has been building ... over 35 years. M.E. and President, Walton McCarthy, ... NBC Weapon Fundamentals and Shelter Engineering Standards, Sixth ... on shelter engineering. McCarthy is considered the leading ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 Absolute Surgical Specialists, ... many of the NALA’s businesses throughout the country participating in ... to participate in the nationwide event as he understands what ... Colonel in the Army. He said, “I wanted to give ... I serve, but I live here too.” , Shop Local ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 The ... ranging from irritable bowel syndrome (IBS) to bloating, ... among the most long-lasting, embarrassing, frustrating and difficult ... foods for digestive health have provided a ... are many factors contributing to digestive health issues, ...
Breaking Medicine News(10 mins):Health News:Communities of Distinction TV Presents May Air Dates for Dallas-Ft. Worth, Texas 2Health News:Hidden Dangers Dog Dog Parks 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 3Health News:Dr. Craig Amshel of Absolute Surgical Specialists Offering Bowel Prep During the Shop Local for a Cause Event 2Health News:Natural Foods For Digestive Health Report and Video Published by BetterDigestion.org 2
... acts in New York and Washington DC, air transportation ... several days, which severely affected the production and distribution ... due to their specific nature. These products are either ... component, and are used in diagnosis or therapy based ...
... your diet can affect your vision, according to a new ... of the eye causing fuzziness, shadows and severe visual impairment. ... diet has been implicated in its development. // ... a study of 349 individuals aged 55 to 80 with ...
... about the dramatic rise in overseas drug testing and ... experimental medicines and Americans who buy products based on ... outside the United States who voluntarily report their experiments ... dwarfing the agency's ability to inspect the test sites. ...
... by high rates of relapse, even after prolonged drug abstinence. ... Medical Center in the Netherlands and the intramural laboratories of ... process in the brain that may lead to a new ... // , In studies using rats, the ...
... Newborns are more likelier to develop a serious ... antibiotic erythromycin, say US scientists., ,A research team ... to pyloric stenosis, a condition that affects about 1 ... cause of abdominal surgery in infants. ,Using ...
... of drug-resistant E. coli has emerged as a possible ... a normal inhabitant of the digestive tract that can ... E. coli from bad food is a frequent cause ... were thought until now to result mostly from inadvertent ...
Cached Medicine News: